Sun Pharma Launches Authorized Generic for Welchol Tab in US | CORPORATE ETHOS

Sun Pharma Launches Authorized Generic for Welchol Tab in US

By: | May 18, 2018
sun pharma

May 18: Mumbai-based drug maker Sun Pharmaceutical Industries Ltd on Thursday announced that one of its wholly owned subsidiaries has launched in US, the Authorized Generic (AG) version for Japan-based Daiichi Sankyo Inc.’s Welchol (colesevelam hydrochloride) 625mg tablets.

According to the company, the current launch is pursuant to a distribution and supply agreement between Sun Pharma’s wholly owned subsidiary and Daiichi Sankyo Inc., which grants the Sun Pharma subsidiary, exclusive rights to distribute these tablets in the US for a pre-determined period.

Welchol Tablets recorded US sales of approximately US$ 520 million for the 12 months ending March 2018, as per IQVIA.

Sun Pharma shares were trading in red at Rs 467.35, down 2.66% from the previous closing of Rs 480.10, on BSE at 2.18 pm today.